Ku ya 28 Gashyantare 2026, Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi (NMPA) cyemeje ku mugaragaro kwamamaza JMKX001899 sulfate mu kuvura abarwayi bakuru barwaye kanseri y’ibihaha ya KRAS G12C-mutated advanced non-small cell (NSCLC) bamaze nibura guhabwa ubuvuzi bumwe mbere.
JMKX001899 ni umuti ugabanya cyane KRAS G12C kandi mbere yaho yahawe izina rya "Breakthrough Therapy" na NMPA.
Amakuru y'ingenzi ku buvuzi arashimishije:
- Igipimo cy’ubutabazi bw’ibanze (ORR) cyageze kuri 55.2%
- Igipimo cy'amezi 12 yo kubaho (OS) cyageze kuri 60.4%
Uretse amakuru meza ku nyungu zo kubaho, JMKX001899 inanoza cyane uburyo umurwayi akoresha imiti, ikoresha uburyo bworoshye bwo kuyikoresha "rimwe ku munsi, ibinini bibiri buri gihe," kandi irashobora kwihanganirwa, bityo ikongera uburyo umurwayi yubahiriza imiti igihe kirekire.
Muri iki gihe, inyigo z’ubuvuzi kuri uyu muti zirimo gukorwa ku barwayi bafite ibibyimba bikomeye nka kanseri y’inkondo y’umura ifata ingirabuzimafatizo ifite impinduka za KRAS G12C, zishobora gufasha ubwoko bwinshi bw’abarwayi ba kanseri mu gihe kizaza.
**Kuki wahitamo Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo?**
- **Ikoranabuhanga rigezweho mu buvuzi:** Tugumana amakuru agezweho ku rwego mpuzamahanga mu kuvura kanseri kandi turi mu ba mbere bazanye imiti n'ubuvuzi bushya, harimo na JMKX001899.
- **Itsinda ry'impuguke mu nzego zitandukanye:** Itsinda ryacu rishinzwe gutanga inama rigizwe n'inzobere mu buvuzi bwa kanseri, abaganga b'indwara zo mu maraso, n'abaganga b'indwara bategura gahunda zihariye zo kuvura buri murwayi.
- **Serivisi ihoraho:** Kuva ku nama y'ibanze no gupima imiterere y'umubiri kugeza ku gutegura gahunda yo kuvura, ubuyobozi bw'imiti, no gukurikirana imicungire y'ubuvuzi, dutanga serivisi z'ubuvuzi zinoze kandi zihoraho.
- **Ibidukikije Mpuzamahanga by’Ubuvuzi:** Dufite ubuvuzi bugezweho, dushyiraho ahantu hashyushye kandi heza ho gukira kandi twubahiriza ibyo abarwayi bakomoka mu mico itandukanye bakeneye.
- **Serivisi zo Gushyigikira Indimi:** Dutanga serivisi zo guhindura indimi nyinshi kugira ngo dukureho inzitizi mu itumanaho no kwemeza ko abaganga n'abarwayi bashyikirana neza.
**Twandikire ubu kugirango ubone uburyo bwo kuvura bugezweho**
Niba wowe cyangwa uwo ukunda muhanganye n'ikibazo cya kanseri y'ibihaha idahinduka ya KRAS G12C, nyamuneka hamagara Ishami Mpuzamahanga ry'Ibitaro bya Oncology bya Beijing mu Karere k'Amajyepfo. Itsinda ryacu ry'inzobere rizaguha inama zirambuye z'ubuvuzi n'ubufasha bwo gushaka ubuvuzi mu Bushinwa.
- Gutanga inama kuri telefoni: 400-880-3716
- Ubujyanama kuri WeChat: 17801183037
- Imeri:
- 100085_010@163.com
- myimmnet@163.com
**Ibibazo Bikunze Kubazwa**
**IKIBAZO: Ni gute abarwayi mpuzamahanga bashobora gutegura gahunda y'ubuvuzi mu ishami mpuzamahanga ry'ibitaro bya Beijing Region South Oncology Hospital?**
**A:** Ushobora kutuvugisha ukoresheje telefoni, WeChat, cyangwa imeri. Abahuzabikorwa bacu mpuzamahanga bazagufasha mu gahunda yo kubonana n'abarwayi, harimo no gutanga inyandiko z'ubuvuzi, gahunda yo kwitaba Imana uri kure, no guhabwa viza yo kujya mu Bushinwa.
**Q: Ni angahe abarwayi mpuzamahanga bavurirwa mu Bushinwa?**
**A:** Ikiguzi cyo kuvurwa kiratandukanye bitewe n'imimerere y'umuntu ku giti cye, harimo n'imiti n'igihe cyo kuvurwa. Nyuma yo kutuvugisha, tuzaguha ikigereranyo cy'ikiguzi gishingiye ku mimerere yawe.
**Ikibazo: Ese ibitaro bitanga serivisi zo kugisha inama abantu bari kure?**
**A:** Yego, dutanga serivisi zo kwigira inama abarwayi mpuzamahanga mu buryo bwa videwo, bikwemerera kugirana ikiganiro cy'ibanze n'itsinda ryacu ry'inzobere mbere yo kujya mu Bushinwa kugira ngo usobanukirwe gahunda y'ubuvuzi n'ibisubizo byitezwe.
Igihe cyo kohereza ubutumwa: Werurwe-04-2026